12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Celivarone: Development discontinued

Sanofi disclosed in its 2Q11 earnings that it discontinued development of celivarone to prevent shocks and major clinical outcomes in...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >